AstraZeneca shares fall 9% after heart drug trial falls short of target

Actions of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug failed to…

Walmart and CVS step in to help seniors

A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…